Skip to main content
CD

Convergent Dental

Convergent Dental offers the Solea® All‑Tissue Laser, an FDA‑cleared 9.3 µm CO₂ laser that vaporizes enamel and cuts hard and soft oral tissues without drills, injections, or sutures. The system enables anesthesia‑free, blood‑free procedures across restorative, periodontal, implant and cosmetic dentistry, reducing chair time and postoperative discomfort. Integrated safety controls, modular accessories and cloud‑based training support rapid adoption and consistent clinical outcomes.

Waltham, United States1097K+ followers
Updated 2 months ago

Funding

$5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

GIL
Funding rounds are not available yet.

Founders

Product

Problem

Dental procedures that rely on drills and injections often cause pain, bleeding, and the need for sutures, leading to patient anxiety and longer chair time. These factors limit practice efficiency and can reduce treatment acceptance, especially for pediatric and anxious patients. Traditional instruments also restrict the ability to perform minimally invasive, same‑day dentistry across a range of hard‑ and soft‑tissue applications.

Solution

Convergent Dental’s Solea® All‑Tissue Laser is an FDA‑cleared CO₂ laser system that delivers a 9.3‑micron wavelength optimized for hydroxyapatite absorption, enabling rapid vaporization of enamel and precise cutting of both hard and soft oral tissues. The platform provides anesthesia‑free, blood‑free, and suture‑free treatment, allowing clinicians to complete restorations, periodontal therapy, implant site preparation, and cosmetic procedures without conventional drills or needles. Integrated safety controls and ergonomic handheld delivery ensure consistent performance across multiple dental specialties. By eliminating the need for injections and suturing, Solea reduces procedure time, accelerates healing, and improves patient comfort, which can increase case acceptance and practice revenue. The system is supported by optional modules—Perioguide for periodontal surgery, Sleep for airway procedures, and Protect for soft‑tissue management—expanding the scope of services a practice can offer. Cloud‑based training and analytics tools help dentists adopt the technology quickly and monitor clinical outcomes.

Target Audience

The primary customers are general dentists, pediatric dentists, oral surgeons, and implant or cosmetic dentistry specialists seeking to increase efficiency, expand procedural offerings, and improve patient comfort.

Features

  • FDA‑cleared 9.3 µm CO₂ laser that matches the peak absorption of hydroxyapatite for efficient enamel vaporization
  • Dual‑mode operation for hard‑tissue (cavities, crown prep, implant osteotomy) and soft‑tissue (gingival recontouring, frenectomies) procedures
  • Anesthesia‑free, blood‑free, and suture‑free workflow that reduces chair time and postoperative discomfort
  • Integrated real‑time safety monitoring (temperature, pulse‑width control) and ergonomic handheld delivery unit
  • Modular accessories: Perioguide™ for minimally invasive periodontal therapy, Sleep™ for airway and sleep‑apnea interventions, Protect™ for soft‑tissue sealing
  • Compatibility with restorative, pediatric, implant, and cosmetic dentistry workflows via interchangeable handpieces and software presets
  • Cloud‑based training portal and outcome analytics dashboard for practice adoption and performance tracking
This profile is AI-generated and may contain inaccuracies.